Skip to main content
ISRG
NASDAQ Industrial Applications And Services

Intuitive Surgical Q2 Earnings: 19% Revenue Growth, $2.80 Non-GAAP EPS, Raises Procedure Outlook

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$372
Mkt Cap
$142.49B
52W Low
$378.5
52W High
$603.88
52W Position info
1.7% below low
Off High info
38% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

ISRG is trading near its 52-week low of $378.5 (1.7% below the low) on elevated volume (2.0× avg).

Summary

Intuitive Surgical reported Q2 2026 revenue of $2.89 billion (+19% YoY) and non-GAAP EPS of $2.80, beating expectations. Procedure growth accelerated to 16%, and the company raised its full-year da Vinci procedure growth outlook to 13.5%-15.5%.


Key Events · Earnings and Guidance · ISRG

  • Q2 Revenue +19% to $2.89B

    Revenue rose 19% YoY to $2.89 billion, driven by 16% procedure growth and higher system placements. Instruments & accessories revenue grew 18% to $1.73 billion, systems revenue up 19% to $685 million.

  • Non-GAAP EPS $2.80 vs $2.19

    Non-GAAP net income reached $1.00 billion, or $2.80 per diluted share, compared to $0.80 billion, or $2.19 per share, in Q2 2025. GAAP EPS was $2.29 vs $1.81.

  • Procedure Growth Accelerates to 16%

    Worldwide procedures grew ~16% YoY, with da Vinci up ~15% and Ion up ~36%. The company raised its full-year da Vinci procedure growth outlook to 13.5%-15.5%, expecting to be near the midpoint.

  • Da Vinci 5 Drives System Placements

    Placed 468 da Vinci systems (246 da Vinci 5) vs 395 in Q2 2025. Installed base reached 11,710 da Vinci systems (+12% YoY) and 1,096 Ion systems (+21% YoY).


Analysis · ISRG · Industrial Applications And Services

Intuitive Surgical delivered a strong Q2, with revenue rising 19% to $2.89 billion and non-GAAP EPS of $2.80 beating the year-ago $2.19. Procedure growth accelerated to 16%, driven by da Vinci 5 adoption and Ion's 36% surge. The company raised its full-year da Vinci procedure growth outlook to 13.5%-15.5%, signaling confidence in sustained demand. With $8.63 billion in cash and aggressive buybacks, the quarter reinforces Intuitive's dominance in robotic surgery, though tariff risks remain a watchpoint.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51.2% of the 201 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ISRG was trading at $372.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $142.5B. The 52-week trading range was $378.50 to $603.88. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ISRG - Latest Insights

ISRG
Oct 21, 2026, 5:14 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $427.26
Real-time Price: $463.31 info
Change: +$36.05 (+8%) info
Market Cap: $162.41B info
ISRG
Oct 21, 2026, 11:55 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $432.01
Real-time Price: $463.31 info
Change: +$31.30 (+7%) info
Market Cap: $162.41B info
ISRG
Oct 20, 2026, 5:07 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $407.00
Real-time Price: $463.31 info
Change: +$56.31 (+14%) info
Market Cap: $162.41B info
ISRG
Oct 20, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $439.00
Real-time Price: $463.31 info
Change: +$24.31 (+6%) info
Market Cap: $162.41B info
ISRG
Sep 14, 2026, 2:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $369.11
Real-time Price: $463.31 info
Change: +$94.20 (+26%) info
Market Cap: $162.41B info